Literature DB >> 10089307

The structure of mouse tumour-necrosis factor at 1.4 A resolution: towards modulation of its selectivity and trimerization.

K J Baeyens1, H L De Bondt, A Raeymaekers, W Fiers, C J De Ranter.   

Abstract

The 1.4 A resolution structure of recombinant mouse tumour-necrosis factor alpha (mTNF) at 100 K has been determined. The crystals are triclinic, space group P1, with unit-cell parameters a = 48.06, b = 48.18, c = 51.01 A, alpha = 114.8, beta = 103.6, gamma = 91.1 degrees. The structure was refined to a final crystallographic R value of 19.7% (Rfree = 23.3%), including 3477 protein atoms, one 2-propanol molecule, one Tris molecule and 240 water molecules. Throughout the crystal lattice, the trimers are differently packed compared with human TNF, which was crystallized in the tetragonal space group P41212 and refined to 2.6 A resolution. The structures of mTNF and human TNF are very similar, diverging mainly in regions that are either flexible and/or involved in crystal packing. Some loops in mTNF which contain residues important for receptor binding are better resolved than in human TNF, such as the surface-exposed loops 30-34 and 144-147, which are also important for receptor specificity. Compared with human TNFs, the channel formed by the three monomers in mTNF is narrower. One 2-propanol molecule trapped in the trimeric channel could be a lead compound for the design of TNF inhibitors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089307     DOI: 10.1107/s0907444998018435

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  13 in total

1.  Anginex, a designed peptide that inhibits angiogenesis.

Authors:  A W Griffioen; D W van der Schaft; A F Barendsz-Janson; A Cox; H A Struijker Boudier; H F Hillen; K H Mayo
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  Expanding the Concepts in Protein Structure-Function Relationships and Enzyme Kinetics: Teaching using Morpheeins.

Authors:  Sarah H Lawrence; Eileen K Jaffe
Journal:  Biochem Mol Biol Educ       Date:  2008       Impact factor: 1.160

3.  Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptide.

Authors:  Ruud P M Dings; Monica M Arroyo; Nathan A Lockwood; Loes I van Eijk; Judy R Haseman; Arjan W Griffioen; Kevin H Mayo
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

4.  Computational modeling of laminin N-terminal domains using sparse distance constraints from disulfide bonds and chemical cross-linking.

Authors:  Stefan Kalkhof; Sebastian Haehn; Mats Paulsson; Neil Smyth; Jens Meiler; Andrea Sinz
Journal:  Proteins       Date:  2010-10-11

5.  The anti-angiogenic peptide anginex disrupts the cell membrane.

Authors:  Jan Pilch; Carla M Franzin; Lynn M Knowles; Fernando J Ferrer; Francesca M Marassi; Erkki Ruoslahti
Journal:  J Mol Biol       Date:  2005-12-20       Impact factor: 5.469

Review 6.  TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy.

Authors:  Sameer Quazi
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

7.  Immunochemical termination of self-tolerance.

Authors:  Jan Grünewald; Meng-Lin Tsao; Roshan Perera; Liqun Dong; Frank Niessen; Ben G Wen; Diane M Kubitz; Vaughn V Smider; Wolfram Ruf; Marc Nasoff; Richard A Lerner; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

8.  Shape shifting leads to small-molecule allosteric drug discovery.

Authors:  Sarah H Lawrence; Ursula D Ramirez; Lei Tang; Farit Fazliyez; Lenka Kundrat; George D Markham; Eileen K Jaffe
Journal:  Chem Biol       Date:  2008-06

9.  Creation of mouse TNFR2-selective agonistic TNF mutants using a phage display technique.

Authors:  Daisuke Ando; Masaki Inoue; Haruhiko Kamada; Shintaro Taki; Takeshi Furuya; Yasuhiro Abe; Kazuya Nagano; Yasuo Tsutsumi; Shin-Ichi Tsunoda
Journal:  Biochem Biophys Rep       Date:  2016-06-08

10.  Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα.

Authors:  W Mark Abbott; Melanie Snow; Sonia Eckersley; Jonathan Renshaw; Gareth Davies; Richard A Norman; Peter Ceuppens; Jerry Slootstra; Joris J Benschop; Yoshitomo Hamuro; Jessica E Lee; Peter Newham
Journal:  Biosci Rep       Date:  2013-08-23       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.